scholarly article | Q13442814 |
P2093 | author name string | Suzuki K | |
Itoh Y | |||
Kohn LD | |||
Klinman DM | |||
Ishii KJ | |||
Takeshita F | |||
Matoba H | |||
Coban C | |||
P2860 | cites work | DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. | Q38305300 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2602-2607 | |
P577 | publication date | 2001-09-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Genomic DNA released by dying cells induces the maturation of APCs | |
P478 | volume | 167 |
Q54631516 | A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. |
Q42056136 | A role for the heat shock protein-CD91 axis in the initiation of immune responses to tumors |
Q34330865 | A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation. |
Q79361609 | Activation of autoreactive B cells by CpG dsDNA |
Q35675228 | Activation of inflammasomes by tumor cell death mediated by gold nanoshells |
Q42046465 | Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses |
Q38260733 | Antitumor immunity by magnetic nanoparticle-mediated hyperthermia |
Q91656807 | Cancer Metabolism Drives a Stromal Regenerative Response |
Q34560654 | Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance induction |
Q40062305 | Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity |
Q36422849 | Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors |
Q37153656 | Contamination of DNase Preparations Confounds Analysis of the Role of DNA in Alum-Adjuvanted Vaccines |
Q38345229 | Contribution of Toll-like receptor 9 signaling to the acute inflammatory response to nonviral vectors |
Q54593174 | Contribution of interferon-beta to the immune activation induced by double-stranded DNA. |
Q40907249 | CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells |
Q53849724 | CpG-activated Thy1.2+ dendritic cells protect against lethal Listeria monocytogenes infection. |
Q55267018 | Cytidine-phosphate-guanosine oligodeoxynucleotides in combination with CD40 ligand decrease periodontal inflammation and alveolar bone loss in a TLR9-independent manner. |
Q39516989 | Cytosolic DNA-activated human dendritic cells are potent activators of the adaptive immune response |
Q35895864 | Cytosolic double-stranded DNA as a damage-associated molecular pattern induces the inflammatory response in rat pancreatic stellate cells: a plausible mechanism for tissue injury-associated pancreatitis |
Q34035570 | DAMPening inflammation by modulating TLR signalling |
Q37073737 | DAMPs ramp up drug toxicity |
Q34066361 | DNA containing CpG motifs induces angiogenesis |
Q56897591 | DNA released from dying host cells mediates aluminum adjuvant activity |
Q26859016 | DNA vaccines: a simple DNA sensing matter? |
Q36769183 | Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design |
Q30380000 | Dangers within: DAMP responses to damage and cell death in kidney disease. |
Q36723438 | Demonstration of innate immune responses in the thyroid gland: potential to sense danger and a possible trigger for autoimmune reactions. |
Q35169612 | Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxia |
Q40646535 | Effect of cytofectins on the immune response of murine macrophages to mammalian DNA. |
Q87862429 | Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome |
Q24598045 | Epigenetics of colorectal cancer |
Q33799990 | Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery. |
Q28067414 | Excessive Cytosolic DNA Fragments as a Potential Trigger of Graves' Disease: An Encrypted Message Sent by Animal Models |
Q36107301 | Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen. |
Q33756673 | Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function |
Q38756562 | Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications |
Q37060411 | Heme oxygenase-1 expression protects the heart from acute injury caused by inducible Cre recombinase. |
Q36474285 | Herpes Simplex Virus Type 1 DNA Is Immunostimulatory In Vitro and In Vivo |
Q28248489 | Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells |
Q29615501 | How dying cells alert the immune system to danger |
Q39178654 | Immunogenic cell death: can it be exploited in PhotoDynamic Therapy for cancer? |
Q41766584 | Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA |
Q40483387 | Induction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA. |
Q35826673 | Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination |
Q36218382 | Innate immune recognition of nucleic acids: beyond toll-like receptors |
Q41453719 | Innate immune response after adenoviral gene delivery into skin is mediated by AIM2, NALP3, DAI and mda5. |
Q39741598 | Interactions between Brucella melitensis and human phagocytes: bacterial surface O-Polysaccharide inhibits phagocytosis, bacterial killing, and subsequent host cell apoptosis |
Q43894691 | Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll-like receptor 9-independent pathway |
Q37437339 | Intralesional rose bengal in melanoma elicits tumor immunity via activation of dendritic cells by the release of high mobility group box 1 |
Q30502120 | Investigation of HIFU-induced anti-tumor immunity in a murine tumor model |
Q41902511 | Iron Handling in Tumor-Associated Macrophages-Is There a New Role for Lipocalin-2? |
Q35951845 | Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? |
Q45116951 | Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways. |
Q36130914 | Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B. |
Q83874912 | Maturation of dendritic cells by necrotic thyrocytes facilitates induction of experimental autoimmune thyroiditis |
Q24629263 | Mechanism of dichotomy between CD8+ responses elicited by apoptotic and necrotic cells |
Q37599467 | Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study |
Q47210849 | Methylated CpG-containing plasmid activates the immune system |
Q37002804 | Molecular characteristics of immunogenic cancer cell death. |
Q36732312 | No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation |
Q35791186 | Nonviral DNA vectors for immunization and therapy: design and methods for their obtention |
Q27011448 | Nucleic acids in circulation: are they harmful to the host? |
Q37259198 | Peptidases released by necrotic cells control CD8+ T cell cross-priming |
Q40428518 | Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells |
Q35949884 | Periodontal bacterial DNA suppresses the immune response to mutans streptococcal glucosyltransferase |
Q36370825 | Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation |
Q84931753 | Primary porcine CD11R1+ antigen-presenting cells isolated from small intestinal mucosa mature but lose their T cell stimulatory function in response to cholera toxin treatment |
Q28279623 | Primary sterile necrotic cells fail to cross-prime CD8(+) T cells |
Q52720171 | Regulation of Tumor Progression by Programmed Necrosis. |
Q40447746 | Regulation of dendritic cell interleukin-12 secretion by tumour cell necrosis. |
Q30501320 | Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. |
Q35194151 | Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer |
Q36868662 | Role of Extrachromosomal Histone H2B on Recognition of DNA Viruses and Cell Damage |
Q28246367 | Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of Damage-Associated Molecular Patterns (DAMPs) in human HeLa cells |
Q34307379 | Self DNA from lymphocytes that have undergone activation-induced cell death enhances murine B cell proliferation and antibody production |
Q37948677 | Sensing herpes: more than toll |
Q43881589 | Serum amyloid P component facilitates DNA clearance and inhibits plasmid transfection: implications for human DNA vaccine |
Q38337516 | Single-base oligodeoxyguanosine-binding proteins on nonspecific cytotoxic cells: identification of a new class of pattern-recognition receptors |
Q38121573 | Sterile inflammation in the liver and pancreas |
Q34455462 | The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. |
Q57180728 | The allosteric activation of cGAS underpins its dynamic signaling landscape |
Q40046527 | The induction of HMGB1 release from RAW 264.7 cells by transfected DNA. |
Q34718276 | The inflammatory response to cell death |
Q37716003 | The sterile inflammatory response |
Q42323188 | Titanium ions form particles that activate and execute interleukin-1β release from lipopolysaccharide-primed macrophages |
Q36763663 | Toll or toll-free adjuvant path toward the optimal vaccine development |
Q36403146 | Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus |
Q41912941 | Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin |
Q36402668 | Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. |
Q80149634 | Toll-like receptors and innate immunity |
Q35671392 | Traditional biochemical assays for studying toll-like receptor 9. |
Q27480641 | Transfection of single-stranded hepatitis A virus RNA activates MHC class I pathway |
Q35090683 | Trauma is danger |
Q38208506 | UVB radiation illuminates the role of TLR3 in the epidermis |
Search more.